Debiopharm International SA
Privately held: no public share price
Assets
(1 total)
1Total Assets
0Approved
0Phase 3 / Filed
1Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 1/2 | WEE1 kinaseSmall molecule | Breast CancerGlioblastoma HR+/HER2- Metastatic Breast Cancer |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2028 (1)
September 2028 (1)
Est. primary completion 2028-09 · NCT05765812 · CT.gov ↗
What to watch
Financial reports
No financial reports recorded.